The Scientist

» macular degeneration

Most Recent

image: Women Lose Vision After Stem Cell Treatment

Women Lose Vision After Stem Cell Treatment

By | March 17, 2017

The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration. 

1 Comment

image: Regulators OK Clinical Trials Using Donor Stem Cells

Regulators OK Clinical Trials Using Donor Stem Cells

By | February 6, 2017

Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.

0 Comments

Matching the immunological characteristics of donor retinal cells to those of the recipient can reduce the chance of rejection.

0 Comments

image: Bionic Eye Success

Bionic Eye Success

By | July 23, 2015

An 80-year-old man with age-related vision loss receives a retinal implant that allows him to see basic shapes.

0 Comments

image: Eye Stem Cell Therapy Moves Ahead

Eye Stem Cell Therapy Moves Ahead

By | April 30, 2015

Researchers inject retinal support cells derived from human embryonic stem cells into the eyes of four men with macular degeneration, bolstering evidence of the experimental treatment’s safety.

4 Comments

image: Stimulating Neurons with Light and Gold

Stimulating Neurons with Light and Gold

By | March 12, 2015

Researchers develop a technique to trigger neural activity in culture using light to heat gold nanoparticles.

0 Comments

image: Week in Review: March 24–28

Week in Review: March 24–28

By | March 28, 2014

Synthetic yeast chromosome; human enhancers and promoters mapped; brain-wide map links fly behaviors to neurons; treating eye diseases with nanotechnology

0 Comments

image: An Eye for Stem Cells

An Eye for Stem Cells

By | December 1, 2011

Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.

36 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS